AU2994795A - New oral pharmaceutical formulation containing magnesium salt of omeprazole - Google Patents

New oral pharmaceutical formulation containing magnesium salt of omeprazole

Info

Publication number
AU2994795A
AU2994795A AU29947/95A AU2994795A AU2994795A AU 2994795 A AU2994795 A AU 2994795A AU 29947/95 A AU29947/95 A AU 29947/95A AU 2994795 A AU2994795 A AU 2994795A AU 2994795 A AU2994795 A AU 2994795A
Authority
AU
Australia
Prior art keywords
omeprazole
pharmaceutical formulation
formulation containing
magnesium salt
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU29947/95A
Other versions
AU695723C (en
AU695723B2 (en
Inventor
Siv Inga Bengtsson
Kurt Ingmar Lovgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU2994795A publication Critical patent/AU2994795A/en
Application granted granted Critical
Publication of AU695723B2 publication Critical patent/AU695723B2/en
Publication of AU695723C publication Critical patent/AU695723C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
AU29947/95A 1994-07-08 1995-07-03 New oral pharmaceutical formulation containing magnesium salt of omeprazole Ceased AU695723C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9400679 1994-07-08
WOPCT/SE94/00679 1994-07-08
PCT/SE1995/000816 WO1996001622A1 (en) 1994-07-08 1995-07-03 New oral pharmaceutical formulation containing magnesium salt of omeprazole

Publications (3)

Publication Number Publication Date
AU2994795A true AU2994795A (en) 1996-02-09
AU695723B2 AU695723B2 (en) 1998-08-20
AU695723C AU695723C (en) 1999-05-06

Family

ID=

Also Published As

Publication number Publication date
EE03378B1 (en) 2001-04-16
WO1996001622A8 (en) 1999-12-23
HUT78132A (en) 2000-06-28
KR970704426A (en) 1997-09-06
MX9700152A (en) 1997-04-30
EE9700014A (en) 1997-06-16
HU9700039D0 (en) 1997-02-28
FI970058A0 (en) 1997-01-07
NO970036D0 (en) 1997-01-06
CZ379596A3 (en) 1997-08-13
WO1996001622A1 (en) 1996-01-25
EP0768872A1 (en) 1997-04-23
NZ289958A (en) 1998-09-24
BR9508261A (en) 1997-12-23
PL181265B1 (en) 2001-06-29
PL318464A1 (en) 1997-06-09
NO970036L (en) 1997-01-06
CA2193681A1 (en) 1996-01-25
SK166096A3 (en) 1997-09-10
AU695723B2 (en) 1998-08-20
FI970058A (en) 1997-01-07
IS4398A (en) 1996-12-17

Similar Documents

Publication Publication Date Title
AU3455297A (en) Pharmaceutical composition containing acid addition salt of basic drug
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
IL118637A (en) Oral pharmaceutical compositions of s(+)-ibuprofen
AU6613996A (en) Heterocyclic compounds and pharmaceutical compositions containing them
HU9700039D0 (en) New oral pharmaceutical formulation containing magnesium salt of omeprazole
IL116957A0 (en) Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
AU6418596A (en) Compounds and pharmaceutical compositions containing them
HUP9801749A3 (en) Nodulisporic acid derivatives and pharmaceutical compositions containing them
IL118636A (en) Oral pharmaceutical compositions of S(+)-etodolac
IL122705A (en) 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
IL118250A0 (en) 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof and pharmaceutical compositions containing them
AU4560297A (en) Pharmaceutical microspheres of valproic acid for oral administration
IL114673A (en) Pharmaceutical compositions containing protein for oral administration
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
IL134958A0 (en) Serotonin containing formulation for oral administration and method of use
AU8015398A (en) Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity
AU4486189A (en) Oral liquid pharmaceutical compositions of sulindac
AU7735798A (en) Pharmaceutical composition for oral administration
ZA964517B (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
AU3407597A (en) Useful formulations of acid addition salt drugs
AU1172097A (en) Pharmaceutical composition containing trehalose
HUP9602324A3 (en) Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them
IL123424A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
AU5560694A (en) Pharmaceutical formulations of ibuprofen

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: 03071995

MK14 Patent ceased section 143(a) (annual fees not paid) or expired